LTRN
Lantern Pharma Inc.
Company Overview
| Mkt Cap | $42.98M | Price | $4.01 |
| Volume | 32.32K | Change | +1.01% |
| P/E Ratio | -2.1 | Open | $3.93 |
| Revenue | -- | Prev Close | $3.97 |
| Net Income | $-20.8M | 52W Range | $2.55 - $6.12 |
| Div Yield | N/A | Target | $25.00 |
| Overall | 35 | Value | 60 |
| Quality | -- | Technical | 10 |
No chart data available
Stock Overview
Updated DailyLantern Pharma Inc. (LTRN) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $4.01 with a market capitalization of $42.98 million. The stock is trading in the middle of its 52-week range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows LTRN with a volume of 32K shares. The stock opened down 1.01% from yesterday's close of $3.97. Current analyst estimates project earnings of $NA per share for this year, with next year targeting $NA.
LTRN demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for LTRN include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 523.4%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 03:11 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LTRN | $4.01 | +1.0% | 32.32K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |